One segment of biological products presents a specific opportunity for ag retailers. Several companies have introduced biological technology formulated to blend with a traditional dry bulk fertilizer.

The Nobel Prize in Medicine will never be awarded for excellence in the formulation and manufacture of biologic medicines. That’s understandable. Patients who need these medicines deserve the product ...

The spine biologics market is set for growth due to an aging population with increasing spinal conditions and a shift towards minimally invasive surgeries. Opportunities arise from advanced synthetic ...

The FDA released Feb. 24 the first version of the Purple Book, a new online database of biological product information. The Purple Book is modeled after the Orange Book, a list of every prescription ...

In the second part of our FDA: Drug & Device Team’s series on biological products regulation, we discuss the regulatory pathways for biological products under Section 351 of the Public Health Service ...

The market for insulin and certain other biological products may change in the coming months and years, as a provision in Biologics Price Competition and Innovation Act (BPCIA) goes into effect on ...

Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — A presenter, here, suggested ways that orthopedic surgeons can avoid being scrutinized by the ...

Mirroring legislation facilitating the introduction of generic drugs to compete with branded small-molecule drugs, policymakers created a path for approval of “biosimilars” to reduce prices by ...

This phrase ‘biologicals’ described as an input for cultivating crops initially confused me. After all, isn’t crop production by its very nature a biological process? Plants basically need water, ...

Shares of China Biologic Products (NASDAQ: CBPO) are falling today, down 15.9% as of 10:58 a.m. EDT, after the company announced updates regarding the two buyout offers it has received since June. The ...

Shares of China Biologic Products (CBPO) rose nearly 26% today after CITIC Capital Holdings made an all-cash offer to purchase the company for $110 per share, as reported by Reuters. The Chinese ...

Shares of China Biologic Products (NASDAQ: CBPO) rose nearly 15% today after the company announced that it has received its second buyout offer of the summer. In June, Chinese investment firm CITIC ...